Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 12.75
-0.05 (-0.39%)
Sep 30, 2026, 1:59 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 7.46 billion as of September 29, 2026. Its market cap has decreased by -27.30% in one year.
Market Cap
7.46B
Enterprise Value
4.26B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.75
ChartMarket Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 7.46B, a decrease of -67.46%. That is a compound annual growth rate of -29.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 7.46B | -16.51% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TWi Biotechnology | 10.46B |
| TCM Biotech International | 9.87B |
| Polaris Group | 8.88B |
| Tanvex BioPharma | 8.03B |
| PharmaEngine | 7.97B |
| Locus Cell | 7.70B |
| Adimmune | 7.54B |
| AnnJi Pharmaceutical | 7.30B |